Keyphrases
Small Molecules
100%
Bleomycin-induced Pulmonary Fibrosis
100%
SHIP1
100%
Lung
75%
Bleomycin
75%
Pirfenidone
75%
Mouse Model
25%
Therapeutic Potential
25%
Phosphatase
25%
Disease Severity
25%
Therapeutic Effect
25%
Phosphoinositide 3-kinase (PI3K)
25%
Orally Administered
25%
Disease Progression
25%
Inflammatory Pathways
25%
Improved Survival
25%
Histopathological Changes
25%
CD-1 Mice
25%
Immunoreactivity
25%
Cell Infiltration
25%
Negatively Regulate
25%
Prophylactic Effect
25%
Total Leukocytes
25%
Collagen Content
25%
PI3K Pathway
25%
Neutrophil Activation
25%
Soluble Collagen
25%
Initiating Treatment
25%
Lung Histology
25%
Intratracheal Administration
25%
Bleomycin-induced Lung Injury
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin
100%
Bleomycin-Induced Pulmonary Fibrosis
100%
Pirfenidone
100%
Mouse Model
33%
Therapeutic Effect
33%
Disease Exacerbation
33%
Disease Severity
33%
Dexamethasone
33%
CD-1 Mouse
33%
Bleomycin-Induced Lung Injury
33%
Phosphatase
33%